X

DON'T SHARE NUISANCE.
SHARE NEWS.

Be a responsible citizen. Come, pledge to always check and share verified and vetted news.
»
1-min read

Compulsory licencing of Bayer's cancer drug is a triumph

Dinesh Narayanan |

Updated: May 12, 2012, 2:17 PM IST
facebook Twitter google skype whatsapp
Compulsory licencing of Bayer's cancer drug is a triumph
WHO's country head Nata Menabde tells Forbes India that governments should take measures to improve access to life-saving drugs, but be sensitive to pharmaceutical industry's concerns.
First Published: May 12, 2012, 2:17 PM IST
Read full article
Next Story
facebook Twitter google skype whatsapp